3.67
price down icon3.42%   -0.13
pre-market  시장 영업 전:  3.84   0.17   +4.63%
loading

Salarius Pharmaceuticals Inc (SLRX) 재무 분석

손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
기간 3개월 3개월 3개월 3개월 3개월
Revenues
-
- - - -
Operating Expenses
43.82%
0.9656
1.7187 1.4887 1.0065 1.4675
Operating Income/Loss
43.82%
-0.9656
-1.7187 -1.4887 -1.0065 -1.4675
Income/Loss From Continuing Operations Before Tax
43.97%
-0.9578
-1.7095 -1.4639 -0.9721 -1.4244
Income/Loss From Continuing Operations After Tax
43.97%
-0.9578
-1.7095 -1.4639 -0.9721 -1.4244
Net Income/Loss
43.97%
-0.9578
-1.7095 -1.4639 -0.9721 -1.4244
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
27.58%
2.1229
1.6639 0.1608 1.2819 0.6004
Diluted Average Shares
27.58%
2.1229
1.6639 0.1608 1.2819 0.6004
Basic Earnings Per Share
56.31%
-0.45
-1.03 -0.66 -0.76 -2.37
Diluted Earnings Per Share
56.31%
-0.45
-1.03 -0.66 -0.76 -2.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.66
price down icon 2.36%
$84.81
price up icon 1.10%
$30.67
price up icon 4.57%
$98.62
price up icon 0.53%
$144.01
price up icon 1.67%
biotechnology ONC
$340.70
price up icon 2.36%
자본화:     |  볼륨(24시간):